The analysis of the collection of human cancers available from The Cancer Genome Atlas (TCGA) indicates HMGA2 and RPSAP52 expression is specially increased in adrenocortical carcinoma, mesothelioma and in the sarcoma samples available (as measured by Z-score, Supplementary Fig. 4a). This evidence concerns the gene HMGA2 and mesothelioma.